Literature DB >> 9714781

Use of deuterium oxide to measure de novo fatty acid synthesis in normal subjects consuming different dietary fatty acid composition1.

S D Konrad1, S L Cook, Y K Goh, M A French, M T Clandinin.   

Abstract

The effect of dietary linoleic (C18:2n-6) and palmitic acids (C16:0) on rate of hepatic de novo fatty acid synthesis was assessed in normal subjects. The diet was formulated to provide combinations of high and low levels of C18:2n-6 and C16:0. After 21 days of diet treatment, plasma triacylglycerol level and incorporation of deuterium into the plasma very low density lipoprotein triacylglycerol (VLDL-TG) pool over 24 hours was measured. Plasma triacylglycerol levels were within the normal range. Increasing dietary intake of linoleic acid decreased plasma triacylglycerol level when subjects consumed a low level of dietary palmitic acid. The relative and net amount of de novo synthesized fatty acid in the plasma VLDL-TG pool was not influenced by the diet treatments. A relationship between plasma triacylglycerol level and rate of hepatic de novo fatty acid synthesis was observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714781     DOI: 10.1016/s0005-2760(98)00061-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.

Authors:  Giuseppina Costabile; Giuseppe Della Pepa; Dominic Salamone; Delia Luongo; Daniele Naviglio; Valentina Brancato; Carlo Cavaliere; Marco Salvatore; Paola Cipriano; Marilena Vitale; Alessandra Corrado; Angela Albarosa Rivellese; Giovanni Annuzzi; Lutgarda Bozzetto
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

2.  Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes.

Authors:  M S Wilke; M A French; Y K Goh; E A Ryan; P J Jones; M T Clandinin
Journal:  Diabetologia       Date:  2009-06-18       Impact factor: 10.122

Review 3.  Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.

Authors:  Sabina Paglialunga; Clayton A Dehn
Journal:  Lipids Health Dis       Date:  2016-09-17       Impact factor: 3.876

4.  De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.

Authors:  Jennifer E Lambert; Edmond A Ryan; Alan B R Thomson; Michael T Clandinin
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.